NASDAQ:BHST BioHarvest Sciences (BHST) Stock Price, News & Analysis $2.06 +0.02 (+0.98%) As of 08/21/2026 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOwnershipSEC Filings About BioHarvest Sciences Stock (NASDAQ:BHST) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BioHarvest Sciences alerts:Sign Up Key Stats Today's Range$2.03▼$2.1750-Day Range$1.92▼$3.3852-Week Range$1.82▼$12.80Volume9,202 shsAverage Volume84,991 shsMarket Capitalization$40.41 millionP/E RatioN/ADividend YieldN/APrice Target$6.50Consensus RatingHold Company Overview BioHarvest Sciences Inc. is a biotechnology company that specializes in the development and commercialization of plant-based active ingredients through proprietary cell-culture technology. By growing undifferentiated plant cells in controlled bioreactor environments, the company aims to produce full-spectrum phytonutrients and botanical compounds that are difficult to obtain through traditional farming methods. This approach is designed to deliver consistent, high-purity extracts with reduced environmental impact and supply-chain variability. The company’s product portfolio focuses on applications across the cosmeceutical, nutraceutical and health-and-wellness markets. Utilizing its “living plant cell” methodology, BioHarvest Sciences creates concentrates rich in natural antioxidants, peptides and other bioactive molecules. These ingredients are formulated for skin-care serums, dietary supplements and functional beverages, targeting consumers and manufacturers seeking clean-label and scientifically backed botanical solutions. BioHarvest Sciences has pursued collaborative partnerships with research institutions and commercial enterprises to advance its cell-culture platform and expand market reach. While its technology development is headquartered in North America, the company’s ingredients have attracted interest from cosmetics and food firms in Europe and Asia. As it continues to scale production and refine its bioreactor processes, BioHarvest Sciences positions itself at the intersection of cellular agriculture and plant-derived therapeutics.AI Generated. May Contain Errors. Read More BioHarvest Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks59th Percentile Overall ScoreBHST MarketRank™: BioHarvest Sciences scored higher than 59% of companies evaluated by MarketBeat, and ranked 81st out of 169 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.8 / 5Analyst RatingHold Consensus RatingBioHarvest Sciences has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialBioHarvest Sciences has a consensus price target of $6.50, representing about 215.5% upside from its current price of $2.06.Amount of Analyst CoverageBioHarvest Sciences has only been the subject of 3 research reports in the past 90 days.Read more about BioHarvest Sciences' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for BioHarvest Sciences are expected to grow in the coming year, from ($0.58) to ($0.42) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of BioHarvest Sciences is -3.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BioHarvest Sciences is -3.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBioHarvest Sciences has a P/B Ratio of 2.04. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.37% of the float of BioHarvest Sciences has been sold short.Short Interest Ratio / Days to CoverBioHarvest Sciences has a short interest ratio ("days to cover") of 0.99, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in BioHarvest Sciences has recently increased by 0.69%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBioHarvest Sciences does not currently pay a dividend.Dividend GrowthBioHarvest Sciences does not have a long track record of dividend growth. News and Social Media1.8 / 5News SentimentN/A News SentimentBioHarvest Sciences has a news sentiment score of -1.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.67 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 1 news article for BioHarvest Sciences this week, compared to 3 articles on an average week.Search Interest1 people have searched for BHST on MarketBeat in the last 30 days. MarketBeat Follows1 people have added BioHarvest Sciences to their MarketBeat watchlist in the last 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, BioHarvest Sciences insiders have not sold or bought any company stock.Percentage Held by InstitutionsBioHarvest Sciences has minimal institutional ownership at this time.Read more about BioHarvest Sciences' insider trading history. Receive BHST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioHarvest Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BHST Stock News HeadlinesHC Wainwright Issues Negative Forecast for BHST EarningsAugust 16, 2026 | americanbankingnews.comRoth Capital Has Lowered Expectations for BioHarvest Sciences (NASDAQ:BHST) Stock PriceAugust 14, 2026 | americanbankingnews.comDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monetary reset tied to executive order 14241 - one he says could draw a sharp dividing line between prepared investors and those left behind. The last time America reset its money - under Nixon in the 1970s - it produced an average of 1,300 new millionaires per day for over 50 years. Stansberry's new documentary names a core group of assets he believes are positioned to surge as Trump's new dollar rolls out. Watch Porter Stansberry's full briefing and get his three steps to prepare before December.August 22 at 1:00 AM | Porter & Company (Ad)Maxim Group Reaffirms Their Buy Rating on BioHarvest Sciences (BHST)August 13, 2026 | theglobeandmail.comBioHarvest Sciences (BHST) Q2 2026 Earnings Call TranscriptAugust 13, 2026 | finance.yahoo.comBioHarvest Sciences Inc. (BHST) Q2 2026 Earnings Call TranscriptAugust 11, 2026 | seekingalpha.comBioHarvest Sciences shares surge 11% after major fragrance manufacturing dealAugust 11, 2026 | msn.comBioHarvest posts higher Q2 revenue, secures manufacturing deal for premium fragrance compoundAugust 11, 2026 | proactiveinvestors.comSee More Headlines BHST Stock Analysis - Frequently Asked Questions How have BHST shares performed this year? BioHarvest Sciences' stock was trading at $5.19 on January 1st, 2026. Since then, BHST shares have decreased by 60.3% and is now trading at $2.06. How were BioHarvest Sciences' earnings last quarter? BioHarvest Sciences Inc. (NASDAQ:BHST) announced its quarterly earnings results on Tuesday, August, 11th. The company reported ($0.17) EPS for the quarter, missing the consensus estimate of ($0.13) by $0.04. The business earned $8.84 million during the quarter, compared to analyst estimates of $9.45 million. BioHarvest Sciences had a negative net margin of 31.21% and a negative trailing twelve-month return on equity of 58.30%. Read the conference call transcript. How do I buy shares of BioHarvest Sciences? Shares of BHST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/11/2026Today8/22/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Personal Care Products Sub-IndustryPersonal Care Products Current SymbolNASDAQ:BHST Previous SymbolNASDAQ:BHST CIK1723464 Webbioharvest.com Phone646-863-2177FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Price Target for BioHarvest Sciences$6.50 High Price Target$8.00 Low Price Target$5.00 Potential Upside/Downside+215.5%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($0.52) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$11.14 million Net Margins-31.21% Pretax Margin-30.94% Return on Equity-58.30% Return on Assets-25.60% Debt Debt-to-Equity RatioN/A Current Ratio2.24 Quick Ratio1.75 Sales & Book Value Annual Sales$35.48 million Price / Sales1.14 Cash FlowN/A Price / Cash FlowN/A Book Value$1.01 per share Price / Book2.04Miscellaneous Outstanding Shares19,616,000Free FloatN/AMarket Cap$40.41 million OptionableN/A Beta0.97 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (NASDAQ:BHST) was last updated on 8/22/2026 by MarketBeat.com Staff. From Our Partners23,281 stocks. Only ONE survived.One American energy producer just cleared a screen of 23281 stocks for elite operating profits, double-digit r...Monument Traders Alliance | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | SponsoredTrump’s New Currency ResetTrump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...Porter & Company | SponsoredElon Musk, Peter Thiel, Sam Altman Are Teaming Up to Back THIS New AIElon Musk, Peter Thiel, and Sam Altman are backing a new AI use case discovered at MIT that has already identi...Stansberry Research | SponsoredA $382 trillion migration and the position no one is talking aboutTrump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...Awesomely | Sponsored"Second Wave” Hitting Iran Soon? Wall Street Issues WarningAnalysts at Goldman Sachs and Morgan Stanley are warning that a quiet domestic threat - unrelated to overseas ...TradeSmith | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioHarvest Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioHarvest Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
